IFNA1 and COVID-19: This observation is well in line with ex vivo data from PBMCs derived from COVID‐19 patients showing highest, monocyte‐specific induction of IFN‐mediated responses that are inversely proportional to the degree of disease (Arunachalam et al, 2020; Schulte‐Schrepping et al, 2020; Stephenson et al, 2021), and the absence of proinflammatory cytokine expression (Arunachalam et al, 2020; Xu et al, 2020a; Stephenson et al, 2021).